Status:
COMPLETED
An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department
Lead Sponsor:
Centre Hospitalier Princesse Grace
Collaborating Sponsors:
Centre Scientifique de Monaco
Pfizer
Conditions:
Pneumococcal Infections
Eligibility:
All Genders
65+ years
Brief Summary
Background : Community-acquired pneumonia (CAP) is a threat in industrialized countries. It represents the 6th cause of death. CAP also frequently associates with other disorders responsible for admi...
Eligibility Criteria
Inclusion
- patients 65-year old and above,
- benefit from French or Monaco social security a social security.
Exclusion
- refuse to participate,
- no possibility to receive SMS,
- impaired cognitive functions and mental status precluding understanding of the study,
- anticipated barriers precluding adequate follow-up (ex. homeless),
- previous APV,
- contraindication to APV,
- do not understand/read French.
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
1475 Patients enrolled
Trial Details
Trial ID
NCT01899365
Start Date
November 1 2015
End Date
October 1 2017
Last Update
January 23 2020
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, France, 63003
2
Centre Hospitalier Paul Ardier
Issoire, France, 63503
3
AP-HM - Hôpital Nord
Marseille, France, 13015
4
AP-HM - La Timone
Marseille, France, 13385